Average cost of multi drug-resistant tuberculosis treatment in China
China: Average cost of multi drug-resistant tuberculosis treatment was 20,028 constant 2022 US$ in 2024. ▲ Rising
Latest (2024)
20,028 constant 2022 US$
Change on year
up 9.7%
World rank
4th
of 92 countries
All-time high
22,007 constant 2022 US$
in 2022
All-time low
2,235 constant 2022 US$
in 2017
Years of data
8
2017–2024
Average cost of multi drug-resistant tuberculosis treatment in China, 2017–2024
Source: WHO (2025) – with minor processing by Our World in Data. Measured in constant 2022 US$.
Analysis
China recorded 20,028 constant 2022 US$ for average cost of multi drug-resistant tuberculosis treatment in 2024.
The figure is up 9.7% on the previous year and up 796.1% over ten years.
That places China 4th out of 92 countries with data for 2024, putting it in the top 10%.
Average cost of multi drug-resistant tuberculosis treatment in China, year by year
| Year | constant 2022 US$ | Change |
|---|---|---|
| 2017 | 2,235 constant 2022 US$ | — |
| 2018 | 7,522 constant 2022 US$ | +236.6% |
| 2019 | 8,246 constant 2022 US$ | +9.6% |
| 2020 | 20,287 constant 2022 US$ | +146.0% |
| 2021 | 21,495 constant 2022 US$ | +6.0% |
| 2022 | 22,007 constant 2022 US$ | +2.4% |
| 2023 | 18,259 constant 2022 US$ | -17.0% |
| 2024 | 20,028 constant 2022 US$ | +9.7% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 6,001 constant 2022 US$ | 2,235 constant 2022 US$ | 8,246 constant 2022 US$ | 3 |
| 2020s | 20,415 constant 2022 US$ | 18,259 constant 2022 US$ | 22,007 constant 2022 US$ | 5 |
Countries ranked near China
More health data for China
- Un projection of annual infant deaths, annual growth rate -1.15 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.0985 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 2,029 deaths per 1,000 people (2090)
- Number of infants who die before age 1 4,642 deaths (2100)
- Total tetanus - number of reported cases, gaps filled 10 (2025)
- Total tetanus - number of reported cases, per capita 0 units per person (2025)
- Diphtheria - number of reported cases, gaps filled 0 (2025)
- Diphtheria - number of reported cases, per capita 0 units per person (2025)
- Measles - number of reported cases, gaps filled 1,770 (2025)
- Measles - number of reported cases, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is average cost of multi drug-resistant tuberculosis treatment in China?
- Average cost of multi drug-resistant tuberculosis treatment in China was 20,028 constant 2022 US$ in 2024, according to WHO (2025) – with minor processing by Our World in Data.
- What is the highest average cost of multi drug-resistant tuberculosis treatment recorded in China?
- The highest recorded value was 22,007 constant 2022 US$ in 2022.
- What is the lowest average cost of multi drug-resistant tuberculosis treatment recorded in China?
- The lowest recorded value was 2,235 constant 2022 US$ in 2017.
- How does China rank for average cost of multi drug-resistant tuberculosis treatment?
- China ranks 4th out of 92 countries with data for 2024.
- Is average cost of multi drug-resistant tuberculosis treatment rising or falling in China?
- Over the last ten years it is up 796.1%. The long-run trend across the full record is rising.
- Where does this China data come from?
- The figures come from WHO (2025) – with minor processing by Our World in Data, published as part of Average cost of multi drug-resistant tuberculosis treatment. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 8 observations, free to reuse under CC BY 4.0 (Our World in Data).
About this data
Average cost of drugs spent per patient starting multidrug-resistant tuberculosis treatment, excluding buffer stock.